Portage Biotech (Portage Biotech) Ending Cash Position : $5.34 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Ending Cash Position?

Portage Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 was $5.34 Mil.

Portage Biotech's quarterly Ending Cash Position declined from Jun. 2023 ($7.70 Mil) to Sep. 2023 ($0.00 Mil) but then increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($5.34 Mil).

Portage Biotech's annual Ending Cash Position increased from Mar. 2021 ($2.77 Mil) to Mar. 2022 ($23.35 Mil) but then declined from Mar. 2022 ($23.35 Mil) to Mar. 2023 ($10.55 Mil).

Portage Biotech Ending Cash Position Historical Data

The historical data trend for Portage Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Ending Cash Position Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Ending Cash Position

Get a 7-Day Free Trial

6.17

3.15

2.77

23.35

10.55

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															13.10	10.55	7.70	-	5.34

Portage Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Portage Biotech's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	23.352	+	-12.807
	=	10.55

Portage Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.445	+	1.896
	=	5.34

Portage Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.